REGENECYTE Trademark

Trademark Overview

On Tuesday, November 9, 2021, a trademark application was filed for REGENECYTE with the United States Patent and Trademark Office. The USPTO has given the REGENECYTE trademark a serial number of 97116530. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Monday, March 25, 2024. This trademark is owned by StemCyte, Inc.. The REGENECYTE trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical cord blood preparations for autologous transplantation, allogeneic transplantation, and human transplant uses derived from human cord blood

General Information

Serial Number97116530
Word MarkREGENECYTE
Filing DateTuesday, November 9, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateMonday, March 25, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 27, 2022

Trademark Statements

Goods and Servicespharmaceutical cord blood preparations for autologous transplantation, allogeneic transplantation, and human transplant uses derived from human cord blood

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 17, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameStemCyte, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBaldwin Park, CA 91706
Party NameStemCyte, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBaldwin Park, CA 91706

Trademark Events

Event DateEvent Description
Friday, November 12, 2021NEW APPLICATION ENTERED
Wednesday, November 17, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 18, 2022ASSIGNED TO EXAMINER
Saturday, August 20, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 7, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 27, 2022PUBLISHED FOR OPPOSITION
Tuesday, September 27, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 22, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, May 22, 2023SOU TEAS EXTENSION RECEIVED
Monday, May 22, 2023SOU EXTENSION 1 FILED
Monday, May 22, 2023SOU EXTENSION 1 GRANTED
Wednesday, May 24, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 22, 2023SOU TEAS EXTENSION RECEIVED
Friday, September 22, 2023SOU EXTENSION 2 FILED
Friday, September 22, 2023SOU EXTENSION 2 GRANTED
Tuesday, September 26, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 25, 2024SOU EXTENSION 3 FILED
Monday, March 25, 2024SOU EXTENSION 3 GRANTED
Monday, March 25, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, March 26, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 25, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 25, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 25, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, October 25, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, November 22, 2024SOU TEAS EXTENSION RECEIVED

Related Keywords

regenecyte human blood transplantation cord uses derived from transplant preparations pharmaceutical